This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Zenith Epigenetics Corp.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Xianghui Wen
Introduction
Xianghui Wen is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. His work is characterized by a focus on innovative methods that enhance the efficacy of treatments.
Latest Patents
Xianghui Wen holds a patent for a "Method of manufacturing a solid form of a BET bromodomain inhibitor." This invention relates to solid crystalline forms of Compound (I), including pharmaceutical compositions and processes for preparing crystalline Compound (I), Form VII. The compound modulates or inhibits the activity of BET bromodomain-containing proteins, making it useful in treating diseases such as cancer, inflammatory conditions, and cardiovascular diseases.
Career Highlights
Wen is currently associated with Zenith Epigenetics Corporation, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health challenges.
Collaborations
Some of his notable coworkers include Feng Wen and Jiahui Chen, who collaborate with him on various projects within the company.
Conclusion
Xianghui Wen's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to improving healthcare solutions. His work continues to have a significant impact on the treatment of serious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile